SE9402422D0 - New beads for controlled release and a pharmaceutical preparation containing the same - Google Patents

New beads for controlled release and a pharmaceutical preparation containing the same

Info

Publication number
SE9402422D0
SE9402422D0 SE9402422A SE9402422A SE9402422D0 SE 9402422 D0 SE9402422 D0 SE 9402422D0 SE 9402422 A SE9402422 A SE 9402422A SE 9402422 A SE9402422 A SE 9402422A SE 9402422 D0 SE9402422 D0 SE 9402422D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical preparation
controlled release
pct
same
preparation containing
Prior art date
Application number
SE9402422A
Other languages
English (en)
Swedish (sv)
Inventor
Hans Arwidsson
Lars Stubberud
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9402422A priority Critical patent/SE9402422D0/xx
Publication of SE9402422D0 publication Critical patent/SE9402422D0/xx
Priority to CA002170526A priority patent/CA2170526A1/en
Priority to PCT/SE1995/000676 priority patent/WO1996001621A1/en
Priority to PL95313386A priority patent/PL313386A1/xx
Priority to AU29936/95A priority patent/AU700949B2/en
Priority to SK303-96A priority patent/SK30396A3/sk
Priority to HU9600575A priority patent/HUT75772A/hu
Priority to NZ289947A priority patent/NZ289947A/en
Priority to CN95190775A priority patent/CN1134108A/zh
Priority to JP8504247A priority patent/JPH09502738A/ja
Priority to MX9600858A priority patent/MX9600858A/es
Priority to RU96107106A priority patent/RU2141822C1/ru
Priority to EE9600034A priority patent/EE03280B1/xx
Priority to EP95926053A priority patent/EP0723434A1/en
Priority to US08/464,773 priority patent/US5783215A/en
Priority to BR9506026A priority patent/BR9506026A/pt
Priority to CZ96731A priority patent/CZ73196A3/cs
Priority to TW084106118A priority patent/TW460300B/zh
Priority to IL11444895A priority patent/IL114448A/xx
Priority to ZA955545A priority patent/ZA955545B/xx
Priority to TR95/00822A priority patent/TR199500822A2/xx
Priority to NO960837A priority patent/NO960837D0/no
Priority to FI961056A priority patent/FI961056A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9402422A 1994-07-08 1994-07-08 New beads for controlled release and a pharmaceutical preparation containing the same SE9402422D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9402422A SE9402422D0 (sv) 1994-07-08 1994-07-08 New beads for controlled release and a pharmaceutical preparation containing the same
CZ96731A CZ73196A3 (en) 1994-07-08 1995-06-07 Novel balls for controlled release and pharmaceutical preparation in which said balls are contained
MX9600858A MX9600858A (es) 1994-07-08 1995-06-07 Nuevas perlas o globulos para liberacion controlada y una preparacion farmaceutica que contiene las mismas.
EE9600034A EE03280B1 (et) 1994-07-08 1995-06-07 Pidurdatud vabanemisega ravimkuulikesed ja neid sisaldav ravimpreparaat
PL95313386A PL313386A1 (en) 1994-07-08 1995-06-07 Novel pearls ensuring controllable drug release and pharmaceutic preparation containing them
AU29936/95A AU700949B2 (en) 1994-07-08 1995-06-07 New beads for controlled release and a pharmaceutical preparation containing the same
SK303-96A SK30396A3 (en) 1994-07-08 1995-06-07 Beads, method for producing them and a pharmaceutical preparation containing the same
HU9600575A HUT75772A (en) 1994-07-08 1995-06-07 New beads for controlled release and a pharmaceutical preparation containing the same
NZ289947A NZ289947A (en) 1994-07-08 1995-06-07 Controlled-release beads having an inert core having a coating comprising hydrophilic polymer and pharmaceutically active substances
CN95190775A CN1134108A (zh) 1994-07-08 1995-06-07 用于控释的新颗粒及含有该颗粒的药物制剂
JP8504247A JPH09502738A (ja) 1994-07-08 1995-06-07 制御放出のための新規ビーズおよびそれらを含有する医薬製剤
CA002170526A CA2170526A1 (en) 1994-07-08 1995-06-07 New beads for controlled release and a pharmaceutical preparation containing the same
RU96107106A RU2141822C1 (ru) 1994-07-08 1995-06-07 Новые гранулы для регулируемого высвобождения и фармацевтические препараты, содержащие такие гранулы
PCT/SE1995/000676 WO1996001621A1 (en) 1994-07-08 1995-06-07 New beads for controlled release and a pharmaceutical preparation containing the same
EP95926053A EP0723434A1 (en) 1994-07-08 1995-06-07 New beads for controlled release and a pharmaceutical preparation containing the same
US08/464,773 US5783215A (en) 1994-07-08 1995-06-07 Pharmaceutical preparation
BR9506026A BR9506026A (pt) 1994-07-08 1995-06-07 Pérolas de liberação controlada processo para a preparação das mesmas preparação farmacêutica processo para a fabricação da mesma uso das pérolas de liberação controlada e processo para o tratamento da hipertensão de edemas e da falha congestiva do coração
TW084106118A TW460300B (en) 1994-07-08 1995-06-15 Controlled release beads, pharmaceutical compositions containing the same and process for the preparation of the same
IL11444895A IL114448A (en) 1994-07-08 1995-07-04 Beads for controlled release process for their preparation and a pharmaceutical preparation containing the same
ZA955545A ZA955545B (en) 1994-07-08 1995-07-04 New beads for controlled release and a pharmaceutical preparation containing the same
TR95/00822A TR199500822A2 (tr) 1994-07-08 1995-07-06 Kontrollü salinim icin yeni taneler ve bunlari iceren farmasötik bir müstahzar.
NO960837A NO960837D0 (no) 1994-07-08 1996-02-29 Nye kuler for regulert frigjöring og et farmasöytisk preparat inneholdende slike
FI961056A FI961056A (fi) 1994-07-08 1996-03-07 Uudet säädetysti vapauttavat helmet ja niitä sisältävä farmaseuttinen valmiste

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402422A SE9402422D0 (sv) 1994-07-08 1994-07-08 New beads for controlled release and a pharmaceutical preparation containing the same

Publications (1)

Publication Number Publication Date
SE9402422D0 true SE9402422D0 (sv) 1994-07-08

Family

ID=20394677

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402422A SE9402422D0 (sv) 1994-07-08 1994-07-08 New beads for controlled release and a pharmaceutical preparation containing the same

Country Status (23)

Country Link
US (1) US5783215A (fi)
EP (1) EP0723434A1 (fi)
JP (1) JPH09502738A (fi)
CN (1) CN1134108A (fi)
AU (1) AU700949B2 (fi)
BR (1) BR9506026A (fi)
CA (1) CA2170526A1 (fi)
CZ (1) CZ73196A3 (fi)
EE (1) EE03280B1 (fi)
FI (1) FI961056A (fi)
HU (1) HUT75772A (fi)
IL (1) IL114448A (fi)
MX (1) MX9600858A (fi)
NO (1) NO960837D0 (fi)
NZ (1) NZ289947A (fi)
PL (1) PL313386A1 (fi)
RU (1) RU2141822C1 (fi)
SE (1) SE9402422D0 (fi)
SK (1) SK30396A3 (fi)
TR (1) TR199500822A2 (fi)
TW (1) TW460300B (fi)
WO (1) WO1996001621A1 (fi)
ZA (1) ZA955545B (fi)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
CA2230748C (en) * 1997-03-14 2010-08-03 American Home Products Corporation Rapamycin formulations for oral administration
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
FR2771291B1 (fr) * 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
CO5070568A1 (es) 1998-05-22 2001-08-28 Eurand Internatrional Spa Proceso de aplicacion de capas y aparato para efectuarlo
SE9803871D0 (sv) * 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
DE19842753A1 (de) * 1998-09-18 2000-03-23 Bayer Ag Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
CA2387973C (en) 1999-11-11 2009-12-22 Pharmacia Ab Pharmaceutical formulation containing tolterodine and its use
CA2456034A1 (en) * 2001-08-03 2003-02-20 Takeda Chemical Industries, Ltd. Sustained-release medicines
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
BR0215262A (pt) * 2001-12-20 2004-12-28 Pharmacia Corp Formas de dosagem com liberação sustentada de ordem zero e processo para a fabricação das mesmas
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
CO5400144A1 (es) 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US7022342B2 (en) * 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
AU2003236947A1 (en) * 2002-06-07 2003-12-22 Ranbaxy Laboratories Limited Modified release, multiple unit drug delivery systems
US7803402B2 (en) * 2002-07-06 2010-09-28 Sanjeev Khandelwal Pharmaceutical preparations
FR2842736B1 (fr) * 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
WO2004072061A1 (en) 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Method of stabilizing lansoprazole
WO2004105735A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Controlled release pharmaceutical compositions of tolterodine and processes for their preparation
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US20050175695A1 (en) * 2003-11-25 2005-08-11 Catherine Castan Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
WO2005123042A1 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Controlled release pharmaceutical formulation
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US11311490B2 (en) 2005-08-10 2022-04-26 Add Advanced Drug Delivery Technologies Ltd. Oral preparation with controlled release
US20070141151A1 (en) * 2005-12-20 2007-06-21 Silver David I Lansoprazole orally disintegrating tablets
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
DK1993559T3 (en) 2006-02-03 2016-10-03 Opko Renal Llc Treatment of vitamin D deficiency and MALFUNCTION with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
RU2008136766A (ru) * 2006-02-24 2010-03-27 Тева Фармасьютикл Индастриес Лтд. (Il) Таблетки метопролола сукцината пролонгированного действия и способы их приготовления
WO2007112581A1 (en) 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
EP2012756A4 (en) * 2006-04-20 2013-01-23 Inventia Healthcare Private Ltd MULTI-UNIT COMPOSITIONS
EP2015735A1 (en) * 2006-04-21 2009-01-21 Synthon B.V. Tolterodine beads
TW200806282A (en) * 2006-05-05 2008-02-01 Wyeth Corp Solid dosage formulations
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
US20090252787A1 (en) * 2006-07-28 2009-10-08 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
DK2481400T3 (da) 2007-04-25 2014-09-29 Opko Ip Holdings Ii Inc Orale præparater med kontrolleret frigivelse omfattende en vitamin D-forbindelse og en voksagtig bærer
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
EP3225243A1 (en) 2007-04-25 2017-10-04 Opko Renal, LLC Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
EP2173329A1 (en) * 2007-07-03 2010-04-14 Synthon B.V. Tolterodine bead
CA2629099A1 (en) * 2008-04-01 2009-10-01 Pharmascience Inc. Novel oral controlled release pharmaceutical formulations
ES2954932T3 (es) 2008-04-02 2023-11-27 Eirgen Pharma Ltd Métodos, composiciones, usos y kits útiles para la deficiencia de vitamina D y trastornos relacionados
WO2010023170A1 (en) * 2008-08-29 2010-03-04 Glaxo Group Limited Dosage form comprising 1-isopropyl-4-{[4-(tetrahydro-2H-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine or a salt thereof
US20140112995A1 (en) * 2009-07-31 2014-04-24 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
US9078830B2 (en) 2009-07-31 2015-07-14 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
AU2014246617A1 (en) 2013-12-23 2015-07-09 Sun Pharmaceutical Industries Limited Multi-layered, multiple unit pharmaceutical compositions
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
GB201417828D0 (en) 2014-10-08 2014-11-19 Cereno Scient Ab New methods and compositions
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
RU2744270C2 (ru) * 2015-12-28 2021-03-04 ЭсЭсПи КО., ЛТД., ДЖАПАН Прессованный фармацевтический препарат
IL243707A0 (en) 2016-01-20 2016-05-01 Galmed Res And Dev Ltd Treatment to regulate the microbiota in the intestine
IL290855B2 (en) 2016-03-28 2024-06-01 Eirgen Pharma Ltd Treatment methods using vitamin D
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN108272766B (zh) * 2018-03-21 2020-07-07 江苏四环生物制药有限公司 一种甲钴胺分散迟释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153105B1 (en) * 1984-02-10 1992-09-09 Benzon Pharma A/S Diffusion coated multiple-units dosage form
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
FR2610327B1 (fr) * 1987-01-30 1989-08-25 Charbonnages Ste Chimique Interpolymere composite a plusieurs couches, son procede de preparation, son application au renforcement de matrices thermoplastiques rigides et compositions renforcees correspondantes
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
NZ230763A (en) * 1988-09-27 1991-10-25 Takeda Chemical Industries Ltd Production of granules having a core by spraying the cores with a dispersion of hydroxypropylcellulose, optionally incorporating an active ingredient
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
EP0447168A3 (en) * 1990-03-16 1993-01-07 Yamanouchi Pharmaceutical Co. Ltd. Long acting granular pharmaceutical composition
DE69111287T2 (de) * 1990-04-18 1995-12-21 Asahi Chemical Ind Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.

Also Published As

Publication number Publication date
NZ289947A (en) 1998-07-28
AU2993695A (en) 1996-02-09
FI961056A (fi) 1996-05-06
FI961056A0 (fi) 1996-03-07
NO960837L (no) 1996-02-29
MX9600858A (es) 1997-06-28
CA2170526A1 (en) 1996-01-25
ZA955545B (en) 1996-01-08
RU2141822C1 (ru) 1999-11-27
EP0723434A1 (en) 1996-07-31
TW460300B (en) 2001-10-21
BR9506026A (pt) 1997-10-14
TR199500822A2 (tr) 1996-06-21
PL313386A1 (en) 1996-06-24
IL114448A0 (en) 1995-11-27
AU700949B2 (en) 1999-01-14
JPH09502738A (ja) 1997-03-18
SK30396A3 (en) 1997-09-10
CZ73196A3 (en) 1996-08-14
US5783215A (en) 1998-07-21
HU9600575D0 (en) 1996-07-29
HUT75772A (en) 1997-05-28
NO960837D0 (no) 1996-02-29
EE03280B1 (et) 2000-08-15
CN1134108A (zh) 1996-10-23
IL114448A (en) 1999-09-22
WO1996001621A1 (en) 1996-01-25

Similar Documents

Publication Publication Date Title
SE9402422D0 (sv) New beads for controlled release and a pharmaceutical preparation containing the same
DK0775018T4 (da) Fremgangsmåde til fremstilling af katalysatorer af cobalt på aluminiumoxid
PT98571A (pt) Dispositivos para a libertacao controlada que utilizam membranas polimerizadas interfacialmente e de processos para a sua preparacao
NO960067D0 (no) Nytt farmasöytisk preparat
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
FI973522A0 (fi) Vesipitoisia, lesitiinipohjaisia irrotteita ja menetelmät niiden käyttämiseksi
BR9506305A (pt) Aparelho e processo para preparação de formas sólidas com desprendimento controlado do ingrediente ativo
MX24568A (es) 3-arilcarbonil-1h-indoles y procedimiento para su preparacion.
MX9205032A (es) 1,2-dihidro-2-oxo-piridinas y procedimiento para su preparacion.
ATE211636T1 (de) Methode zum herstellen eines dentalproduktes
MX26267A (es) Aminobenzodiacepinas y procedimiento para su prepaacion.
DE68904147D1 (de) Kronenetherverbindung und trennmittel.
ATE66371T1 (de) Arzneimittelzubereitung mit verzoegerter freisetzung.
TR25269A (tr) SüBSTITüE EDILMIS BENZANILIDLER VE ILISKILI BENZILAMINLER, HAZIRLANMALARINA MAHSUS USULLER VE HERBISID OLARAK KULLANIMLARI
NO972239D0 (no) Ny replikasjonsprosess
NO901345L (no) Bindemiddel for anvendelse i stoeperier, samt fremgangsmaate for fremstilling av stoepekjerner og -former.
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
KR970704417A (ko) 친유성 히드록시산, 그의 화장제 및 약제학적 용도 및 그의 제조 방법(lipophilic hydroxylated acid, cosmetic and pharmaceutical use thereof and method for preparing same)
EP0329043A3 (en) Optically active rhodium-complexes of 3,4-bis(diarylphosphino)-pyrrolidines, and their use in the preparation of phosphinothricine by asymmetric hydrogenation
DE59004582D1 (de) 1,3-Di-arylmethoxy-4,6-dinitrobenzole, Verfahren zu ihrer Herstellung und Verfahren zur Herstellung von 4,6-Diaminoresorcin.
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
MX9204451A (es) N-azinil-n'-(2-etilsufinil-fenilsulfonil)-ureas y procedimiento para su obtencion.
IT8721945A0 (it) Procedimento per la profumazione di libri, dispositivo per l'attuazione di detto procedimento
SE9404438D0 (sv) New process
NO885406L (no) Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter.